Privacy Statement

The privacy of information provided by you to Elite Pharmaceuticals, Inc. (Elite) via this website is a high priority to us. We have developed this Privacy Policy to explain the treatment of such information.  This policy may be revised or updated from time to time and a statement of the revised policy will be published on this website.

Use of Your Personal Information

We do not sell or rent the personal information you provide us in response to the features available on this website. No information provided to us will be made available to a third party, other than third parties whom Elite has binding agreements with respect to confidentiality or to the extent we are required to do so by law or regulation.

Whenever you provide information over the Internet, that information may be collected and used by others on an unauthorized basis. Therefore, the decision to provide data on-line is yours alone. Elite makes no representations about the privacy statements/policies of affiliated or unaffiliated third parties.

Information we collect on our web site

The information collected on our website allows us to provide the services and/or information you are requesting. For instance, we collect personal information in order to respond to requests for additional information regarding Elite (e.g. information about our service, an investor kit, etc.). In the same sense, we provide the ability for interested parties to receive periodic updates by providing us their email addresses. This website does support the ability to enroll on-line.

In addition to the data you provide us when you fill out our forms, we also collect information automatically during your internet session. We may collect some or all of the following: date, time and duration of your visit, sections/pages viewed, browser used, host, etc. This information is periodically analyzed in the aggregate to improve the content and usefulness of the website.

Questions about this privacy statement should be submitted through the "Contact Us" section in the Corporate Information or Investor Relations sections of the website, using the eliteinfo@elitepharma.com selection.